CD4 + CD25 + regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
Inserm · Université de Bourgogne · +10 more institutions
Abstract
Tumor growth promotes the expansion of CD4+CD25+ regulatory T (T reg) cells that counteract T cell-mediated immune responses. An inverse correlation between natural killer (NK) cell activation and T reg cell expansion in tumor-bearing patients, shown here, prompted us to address the role of T reg cells in controlling innate antitumor immunity. Our experiments indicate that human T reg cells expressed membrane-bound transforming growth factor (TGF)-beta, which directly inhibited NK cell effector functions and down-regulated NKG2D receptors on the NK cell surface. Adoptive transfer of wild-type T reg cells but not TGF-beta-/- T reg cells into nude mice suppressed NK cell-mediated cytotoxicity, reduced NKG2D…
Citation impact
- FWCI
- 16.26
- Percentile
- 100%
- References
- 52
Authors
22- FGFrançois GhiringhelliCorresponding
Inserm, Université de Bourgogne, Université Paris Cité, Université Paris-Saclay
- CMCédric Menard
Inserm, Université Paris Cité, Université Paris-Saclay
- MTMagali Terme
Inserm, Université Paris Cité, Université Paris-Saclay
- CFCaroline Flament
Inserm, Université Paris Cité, Université Paris-Saclay
- JTJulien Taı̈eb
Inserm, Université Paris Cité, Université Paris-Saclay
Topics & keywords
- Interleukin 21
- NKG2D
- IL-2 receptor
- Lymphokine-activated killer cell
- Biology
- Interleukin 12
- Cell biology
- Cytotoxic T cell